Managing Business Risk as a Medical Device Company

Global Medical Device Podcast · 3 May 2021 · 34m · Episode 201

What this episode covers

Michael Cremeans, Life Sciences Industry Practice Leader at Hylant, joins host Jon Speer to discuss how medical device companies can manage enterprise business risk beyond just product safety. They cover the importance of engaging insurance experts early to navigate complex contractual liabilities, such as those found in term sheets and group purchasing organization agreements, and how robust quality systems like those in Greenlight Guru can improve insurance outcomes. Cremeans emphasizes that companies should not treat insurance as an afterthought but rather integrate risk management into their overall business strategy to protect against financial and legal damages.

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 31m

    025 - “The Frying Pan to the Fire” with Edwin Bills

    Edwin Bills, a Risk Management Expert and former committee member for ISO 14971, ISO TR 24971, and AAMI TIR 105, explains the evolution of risk management standards in medical devices and combination products. He details the philosophical differences between ISO 14971 and ICH Q9, emphasizing that risk management must focus on patient safety rather than just regulatory compliance. Bills advises engineers to use qualitative methods early in development and highlights the importance of analyzing interactions between drug and device constituents in combination products. He also discusses the expanded requirements for post-market surveillance in the 2019 standard and the upcoming harmonization of ISO 14971 in Europe.

  • Being an Engineer · 51m

    S5E29 Steve Gompertz | Medical Device Quality Control & Regulatory Requirements

    Steve Gompertz, a partner at QRx Partners with prior leadership roles at Medtronic, Boston Scientific, St. Jude Medical, and Pelican Biothermal, explains how to build scalable quality management systems for medical device companies. He details the evolution of regulatory frameworks, noting the shift toward stricter EU standards and the integration of AI and cybersecurity into device compliance. Gompertz emphasizes tailoring quality systems to company size, using a case study of a client who reduced FDA findings from dozens to zero by implementing a holistic, process-connected system rather than a checklist approach. He also advocates for concurrent engineering and cross-functional teams to accelerate development while maintaining rigorous safety standards.

  • The Manufacturing Executive · 28m

    Not By Accident: Risk Management for Manufacturing Executives w/ Van Carlson

    Van Carlson, founder and CEO of Strategic Risk Alternatives, discusses risk management strategies for manufacturing executives, focusing on the shift from traditional insurance to self-insurance mechanisms like the Section 831(b) tax code. He explains how manufacturers can mitigate rising premiums and coverage gaps by building reserves for unfunded risks such as supply chain disruptions, product recalls, and business interruption. Carlson emphasizes that these tools allow business owners to defer taxes and create a 'war chest' to handle claims without impacting operating cash flow, a practice increasingly vital in the post-pandemic economic landscape.

  • Let's Combinate · 47m

    068 - Benefit/Risk Ratios, PRRC, and Mythical Medical with David Rutledge

    David Rutledge, CEO of Global Strategic Solutions and author of 'Mythical Medical', discusses the critical importance of demonstrating product benefit in medical device development, arguing that the industry has historically focused too heavily on risk. He details the role of the Person Responsible for Regulatory Compliance (PRRC) under EU MDR, emphasizing the need for cross-functional teams to define and validate benefits through diverse data sources. Rutledge also shares insights from his book, using narrative characters to illustrate common regulatory pitfalls, audit preparation strategies, and the emotional weight of ensuring patient safety in combination products.

  • Let's Combinate · 32m

    202 - Becoming an Expert in the Work Nobody Wants to Do/Design, Risk, and the Messy Middle of Combination Products w/Joey Frechin

    Joey Frechin, a Senior Technical Program Manager in med tech consulting, explains the complexities of aligning risk assessments for combination products, noting that while drug and device teams are starting to integrate their processes, significant methodological gaps remain. He details the P1/P2 probability scoring methodology used in ISO 14971 to distinguish between device failure and patient harm, and shares his career strategy of becoming an expert in 'unwanted' but high-value tasks like DFMEA and PFMEA to bridge engineering and quality teams. Frechin also discusses current industry trends, where companies often pivot from complex bespoke designs to simplified or off-the-shelf subsystems to meet clinical trial timelines, highlighting the critical importance of early sterilization and accelerated aging testing to avoid late-stage failures.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.